Forecasts

Help
Analyst
Ticker
Result
Analyst Action
AI Recommendation
Period
Limit
Return %
Filters
Performance Current: Return 2.20% Success Rate 50.0%
Total: 16983 • Pg: 158/850 ← Back Next →
LULU Lululemon
2026-07-16 Truist Financial
Δh% 9.5%
Rating Downgraded Hold
Price Then 117.42
Price h 128.58
Target 94
PANW Palo Alto Networks
2026-07-16 Capital One Financial
Δh% 2.78%
Rating Upgraded Buy
Price Then 354.02
Price h 363.86
Target 421
OKTA Okta
2026-07-16 Capital One Financial
Δh% -1.68%
Rating Upgraded Buy
Price Then 150.86
Price h 148.32
Target 171
NTR Nutrien
2026-07-16 Jefferies
Δh% -5.72%
Rating Downgraded Sell
Price Then 68.33
Price h 64.42
Target 63
SLB SLB
2026-07-16 Barclays
Δh% 6.27%
Target Lowered Buy
Price Then 47.55
Price h 50.53
Target 64
DVN Devon Energy
2026-07-16 Raymond James
Δh% 0.12%
Target Lowered Hold
Price Then 42.93
Price h 42.98
Target 64
JBHT J.B. Hunt Transport Services
2026-07-16 Raymond James
Δh% -2.81%
Target Raised Buy
Price Then 276.28
Price h 268.52
Target 315
BKR Baker Hughes
2026-07-16 Barclays
Δh% 7.51%
Target Lowered Hold
Price Then 57.25
Price h 61.55
Target 72
AVAV AeroVironment
2026-07-16 Raymond James
Δh% 32.23%
Rating Upgraded Hold
Price Then 141.22
Price h 186.73
Target 210
GOOG Alphabet
2026-07-16 UBS
Δh% -4.52%
Update Buy
Price Then 370.21
Price h 353.47
Target 430
AEP American Electric Power
2026-07-16 Goldman Sachs
Δh% -5.11%
Update Sell
Price Then 132.5
Price h 125.73
Target 147
AMZN Amazon
2026-07-16 KeyBanc
Δh% 7.66%
Target Raised Buy
Price Then 254.96
Price h 274.48
Target 335
SPCX SpaceX
2026-07-16 Morgan Stanley
Δh% -1.6%
Update Sell
Price Then 135.27
Price h 133.11
Target 225
RKT Rocket Companies
2026-07-16 Morgan Stanley
Δh% -6.03%
Rating Upgraded Hold
Price Then 14.6
Price h 13.72
Target 19
PNR Pentair
2026-07-16 Stifel Nicolaus
Δh% 7.09%
Update Sell
Price Then 64.33
Price h 68.89
Target 65
MS Morgan Stanley
2026-07-15 Morgan Stanley
Δh% -5.32%
Target Raised Buy
Price Then 228.42
Price h 216.26
Target 241
PNR Pentair
2026-07-15 Goldman Sachs
Δh% 7.09%
Target Lowered Sell
Price Then 64.33
Price h 68.89
Target 72
PNC PNC Financial
2026-07-15 Goldman Sachs
Δh% -0.63%
Target Raised Buy
Price Then 254.15
Price h 252.56
Target 280
CTAS Cintas
2026-07-15 Goldman Sachs
Δh% 5.55%
Target Raised Buy
Price Then 192.37
Price h 203.05
Target 231
NTLA Intellia Therapeutics
2026-07-15 Wolfe Research
Δh% -8.44%
Rating Downgraded Sell
Price Then 13.04
Price h 11.94
Target 9
Date Analyst Stock Action AI at Time Price Then Price h Δh% Target Portfolio
2026-07-16 Truist Financial
LULU Lululemon
Rating Downgraded Hold 117.42 128.58 9.5% 94
2026-07-16 Capital One Financial
PANW Palo Alto Networks
Rating Upgraded Buy 354.02 363.86 2.78% 421
2026-07-16 Capital One Financial
OKTA Okta
Rating Upgraded Buy 150.86 148.32 -1.68% 171
2026-07-16 Jefferies
NTR Nutrien
Rating Downgraded Sell 68.33 64.42 -5.72% 63
2026-07-16 Barclays
SLB SLB
Target Lowered Buy 47.55 50.53 6.27% 64
2026-07-16 Raymond James
DVN Devon Energy
Target Lowered Hold 42.93 42.98 0.12% 64
2026-07-16 Raymond James
JBHT J.B. Hunt Transport Services
Target Raised Buy 276.28 268.52 -2.81% 315
2026-07-16 Barclays
BKR Baker Hughes
Target Lowered Hold 57.25 61.55 7.51% 72
2026-07-16 Raymond James
AVAV AeroVironment
Rating Upgraded Hold 141.22 186.73 32.23% 210
2026-07-16 UBS
GOOG Alphabet
Update Buy 370.21 353.47 -4.52% 430
2026-07-16 Goldman Sachs
AEP American Electric Power
Update Sell 132.5 125.73 -5.11% 147
2026-07-16 KeyBanc
AMZN Amazon
Target Raised Buy 254.96 274.48 7.66% 335
2026-07-16 Morgan Stanley
SPCX SpaceX
Update Sell 135.27 133.11 -1.6% 225
2026-07-16 Morgan Stanley
RKT Rocket Companies
Rating Upgraded Hold 14.6 13.72 -6.03% 19
2026-07-16 Stifel Nicolaus
PNR Pentair
Update Sell 64.33 68.89 7.09% 65
2026-07-15 Morgan Stanley
MS Morgan Stanley
Target Raised Buy 228.42 216.26 -5.32% 241
2026-07-15 Goldman Sachs
PNR Pentair
Target Lowered Sell 64.33 68.89 7.09% 72
2026-07-15 Goldman Sachs
PNC PNC Financial
Target Raised Buy 254.15 252.56 -0.63% 280
2026-07-15 Goldman Sachs
CTAS Cintas
Target Raised Buy 192.37 203.05 5.55% 231
2026-07-15 Wolfe Research
NTLA Intellia Therapeutics
Rating Downgraded Sell 13.04 11.94 -8.44% 9